Dementia with Lewy bodies: neuropathology. J Geriatr Psychiatr Neurol. 2002;15:210–216..
Parkinson's disease neuropathology: later-developing dementia and loss of the Levodopa response. Arch Neurol. 2002;59:102–112., , et al.
Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?Park Relat Disord. 2005;11:S47–S51.,
Dementia with Lewy bodies: diagnosis and management: Third report of the DLB Consortium. Neurology. 2005;65:1863–1872., , et al.
Essentials of the proper diagnosis of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003;78:1290–1308., , .
Continuum, Vol. 10. Minneapolis: American Academy of Neurology, 2004:81–112.. Dementia with Lewy Bodies. In (ed.)
Pathophysiology of REM sleep behavior disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–2788., , et al.
Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006;20:623–636., , et al.
A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatr Clin Neurosci. 2000;12:425–450., , .
Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology. 2000;55:281–288., , et al.
Neuropathologic findings in patients with REM sleep behavior disorder and a neurodegenerative disorder. Neurology. 2001;56:A299., , et al.
Mental and Behavioral Dysfunction in Movement Disorders. Totowa, NJ: Humana Press, 2003:383–397., , et al. REM sleep behavior disorder in Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. In , , et al. (eds.)
A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry. 2001;16:528–536., , , .
Capgras' syndrome in dementia with Lewy bodies. J Geriatr Psychiatr Neurol. 2002;15:239–241., .
Association of REM sleep behavior disorder and neurodegenerative disease. Sleep. 1999;22(Suppl 1):S72., , et al.
Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord. 2001;16:622–630., , et al.
Current management of sleep disturbances in dementia. Cur Neurol Neurosci Rep. 2001;2:169–177., , .
High prevalence of neurovascular instability in neurodegenerative dementias. Neurology. 1998;51:1760–1762., , , .
Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (Berl). 2003;105:341–350., , , .
Autonomic dysfunction in dementia with Lewy bodies. Neurology. 2004;62:1804–1809., , et al.
Diffuse Lewy body disease presenting as multiple system atrophy. Can J Neurol Sci. 1999;26:127–131., , .
Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599–614., , .
Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. J Geriatr Psychiatry Neurol. 2002;15:188–194., .
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 2000;177:252–256., , et al.
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology. 2000;54:1616–1625., , et al.
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dem Geriatr Cog Disord. 2000;11:327–335., , et al.
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181–187., , et al.
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22:1689–1707., , et al.
Occurrence and clinical correlates of REM sleep behavior disorder in patients with Parkinson's disease over time. J Neurol Neurosurg Psychiatry. 2008; 79(4); 387–391., , et al.
Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130:1577–1585., , et al.
Hypocretin (orexin) cell loss in Parkinson's disease. Brain. 2007;130:1586–1595., , .
REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Ger Psychiatr Neurol. 2004;17:146–157., , .
Parkinson Disease: Mind, Mood, and Memory. Miami, FL:National Parkinson Foundation, 2005:54–71., . Sleep Disturbances in Parkinson's disease. In , (eds.)
Mild cognitive impairment preceding dementia with Lewy bodies. Neurology. 2004;62:A86–A87., , et al.
Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007;22:1272–1277., , et al.
Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194..
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006;66:845–851., , , .
REM sleep behavior disorder: a possible early marker for synucleinopathies. Neurology. 2006;66:796–797., .
Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 2007; 8:60–64., , et al.
Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol. 2003;53:774–780., , et al.
Slow-wave sleep and delta power in rapid eye movement sleep behavior disorder. Ann Neurol. 2005;57:277–282., , et al.
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder: comparison with Parkinson's disease and controls. Brain. 2000;123:1155–1160., , et al.
IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep. 2003;26:507–512., , et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters.
Assessing whole brain perfusion changes in REM sleep behavior disorder. Neurology. 2006;67:1618–1622., , et al.
A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep. 2006;29:927–933., , et al.
Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist?Neurology. 2004;62:41–45., , et al.
Combination of “idiopathic” REM sleep behavior disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005;128:126–137., , et al.
Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder. Sleep. 1996;19:367–369., , , .
Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442–1446., , et al.
Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology. 2007;69:1460–1465., , et al.
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236–2238., , et al.
Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121–134., , et al.
Retinal involvement in dementia with Lewy bodies: a clue to hallucinations?Ann Neurol. 2003;54:542–547., , et al.
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS–SPSP International Workshop. Neurology. 1996;47:1–9., , et al.
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129:1385–1398., , et al.
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11:283–296., , et al.
Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol. 1988;45:1194–1199., , et al.
Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology. 1994;44:1264–1270., , et al.
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology. 1995;45:1477–1483., , et al.
Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11:268–273., , et al.
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. Neurocase. 2005;11:204–211., , et al.
REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep. 2005;28:349–354., , et al.
Non-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations. Neurocase. 2006;12:332–338., , .
Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician. Totawa, NJ: Human Press, 2000:253–261.. Corticobasal degeneration. In , (eds.)
Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54:S15–S19., , .
Atypical Parkinsonian Disorders. Totawa, NJ: Humana Press, 2005:309–334.. Corticobasal degeneration: the syndrome and the disease. In (ed.)
Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997;48:959–969., , et al.
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53:795–800., , et al.
Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology. 1996;46:720–726., , , .
Speech and language disorders associated with corticobasal degeneration. J Med Speech-Lang Pathol. 2003;11:131–146., , et al.
Corticobasal Degeneration and Related Disorders, Vol. 82. London: Lippincott, Williams & Wilkins, 2000:147–152., . Neuropsychiatric aspects of corticobasal degeneration. In , , (eds.)
Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci. 2007;19:77–80., , et al.
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702–705., , et al.
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–919., , et al.
Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001;58:383–387., , et al.
Microtubule-associated protein tau; MAPT http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=157140.
A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2008;29:427–435., , et al.
Frontotemporal dementia and parkinsonism associated with the IVS1+1G→A mutation in progranulin: a clinicopathologic study. Brain. 2006;129:3103–3114., , et al.
Null mutations in progranulin cause ubiquitin positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920–924., , et al.
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15:2988–3001., , et al.
Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann Neurol. 2006;60:374–380., , et al.
The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129:3081–3090., , et al.
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain. 2006;129:3115–3123., , et al.
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006;60:314–322., , et al.
Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain. 2006;129:3124–3126., , et al.
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129:3091–3102., , et al.
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–133., , et al.
Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol. 2001;50:741–746., , et al.
Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Park Relat Disord. 2003;9:265–270., , et al.
Distinctive MRI findings in pallido-ponto-nigral degeneration (PPND). Neurology. 2007;68:620–621., , , .
Functional correlates of musical and visual ability in frontotemporal dementia. Br J Psychiatry. 2000;176:458–463., , et al.
Neuroanatomy of the self: evidence from patients with frontotemporal dementia. Neurology. 2001;57:817–821., , et al.
International approaches to frontotemporal dementia diagnosis: from social cognition to neuropsychology. Ann Neurol. 2003;54:S7–S10., , et al.
Double dissociation of social functioning in frontotemporal dementia. Neurology. 2003;60:266–271., , , .
Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology. 2001;56:S6–S10..
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology. 2007;69:1424–1433., , et al.
Clinical–pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Park Relat Disord. 2007;13:230–239., , et al.
Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain. 2005;128:752–772., , et al.
Absence of REM sleep behavior disorder in eleven members of the PPND kindred. Arch Neurol. 2006;63:268–272., , et al.
Physiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17. Autonom Neurosci Basic Clin. 2002;102:71–77., , .
Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Electroenceph Clin Neurophysiol. 1998;107:213–222., , , .